• Medicare Reimbursement: Medicare coverage of breakthrough technologies (H.R. 1691); Transitional Coverage for Emerging Technologies (TCET); CMS NPRM TCET UDI inclusion in Medicare claims form Nursing Workforce Shortage Women's Health Research and Innovation Initiative (Executive Order) FDA Reform: cellular therapy RMAT designation; medical device shortage reporting; domestic production of medical products; use of real world data (RWD) and real world evidence (RWE); (H.R. 3723) Medical Device Electronic Labeling Act FDA appropriations bill for FY 2024 regarding medical device sterilization; FDA modernization
• Research & development tax amortization (S.866/H.R.2673); Neighborhood Homes Investment Tax Credit bill (S.657); Affordable Housing Credit Improvement Act (S. 1557/H.R. 3238); Rural Opportunity Zone and Investment Act (H.R. 3906)
• Patent legislation: beneficiary owner
• USDA Sec. 502 low-income, rural areas in need of affordable housing proposals for workforce development
• EPA regulation of Ethylene Oxide NESHAP Rule and Re-Registration FIFRA PID Rule PFAS issues: Fluoropolymers

Duration: November 1, 2007 to present

General Issues: Health Issues, Taxation/Internal Revenue Code, Copyright/Patent/Trademark, Housing, Clean Air & Water (Quality), Education, Sports/Athletics, Roads/Highway, Veterans, Miscellaneous Tariff Bills, Trade (Domestic & Foreign), Torts, Medicare/Medicaid, Financial Institutions/Investments/Securities

Spending: about $10,910,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2007: House of Representatives, U.S. Senate, Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS), Small Business Administration (SBA), White House Office, Treasury - Dept of, Vice President of the U.S., Veterans Affairs - Dept of (VA), Commerce - Dept of (DOC), U.S. Trade Representative (USTR), Internal Revenue Service (IRS), Executive Office of the President (EOP),, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Natl Economic Council (NEC), Agency for Health Care Policy & Research, Patent & Trademark Office (PTO), Medicare Payment Advisory Commission (MedPAC), Food & Drug Administration (FDA),, Y Y Food and Drug Administration, Y Y Centers for Medicare and Medicaid Services